Evidence map›Paper›PMID 29170418›Full record

ArticleScientific reports2017

Gene Therapy Restores Mfrp and Corrects Axial Eye Length.

Gabriel Velez, Stephen H Tsang, Yi-Ting Tsai, Chun-Wei Hsu, Anuradha Gore, Aliaa H Abdelhakim, MaryAnn Mahajan, Ronald H Silverman, Janet R Sparrow, Alexander G Bassuk and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Retinal glia in myopia: current understanding and future directions.Frontiers in cell and developmental biology · 2024
    Review
  6. Article
  7. Article
  8. Genetic Interaction betweenInternational journal of molecular sciences · 2022
    Article
  9. Ablation of mpeg+ Macrophages Exacerbates mfrp-Related Hyperopia.Investigative ophthalmology & visual science · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. PKM2 ablation enhanced retinal function and survival in a preclinical model of retinitis pigmentosa.Mammalian genome : official journal of the International Mammalian Genome Society · 2020
    Article
  15. Article
  16. Review
  17. Membrane-type frizzled-related protein regulates lipidome and transcription for photoreceptor function.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Gabriel VelezOmics Laboratory, Stanford University, Palo Alto, CA, USA.
Stephen H TsangBernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology and Cell Biology, Institute of Human Nutrition, Columbia University, New York, NY, USA. sht2@columbia.edu.
Yi-Ting TsaiBernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology and Cell Biology, Institute of Human Nutrition, Columbia University, New York, NY, USA.
Chun-Wei HsuBernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology and Cell Biology, Institute of Human Nutrition, Columbia University, New York, NY, USA.
Anuradha GoreOmics Laboratory, Stanford University, Palo Alto, CA, USA.
Aliaa H AbdelhakimBernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology and Cell Biology, Institute of Human Nutrition, Columbia University, New York, NY, USA.
MaryAnn MahajanOmics Laboratory, Stanford University, Palo Alto, CA, USA.
Ronald H SilvermanBernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology and Cell Biology, Institute of Human Nutrition, Columbia University, New York, NY, USA.
Janet R SparrowBernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology and Cell Biology, Institute of Human Nutrition, Columbia University, New York, NY, USA.
Alexander G BassukDepartment of Pediatrics, University of Iowa, Iowa City, IA, USA. alexander-bassuk@uiowa.edu.
Vinit B MahajanOmics Laboratory, Stanford University, Palo Alto, CA, USA. vinit.mahajan@stanford.edu.
Columbia University · USNewYork–Presbyterian Hospital · USStanford University · USSmith-Kettlewell Eye Research Institute · USUniversity of Iowa · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Toward mechanism- and gene-based therapies for retinal degenerationR01EY018213 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stephen H Tsang · 2008 to 2026
$6.6M
Gene Silencing and Gene Editing in PhototransductionR01EY024698 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stephen H Tsang · 2015 to 2026
$4.7M
Structure and Function of Calpain-5R01EY024665 · NEI · UNIVERSITY OF IOWA · PI MAHAJAN, VINIT B · 2015 to 2019
$1.9M
Mechanistic Studies on Regenerative Medicine Approaches to Childhood BlindnessR01EY026682 · NEI · UNIVERSITY OF IOWA · PI BASSUK, ALEXANDER G, MAHAJAN, VINIT B · 2016 to 2019
$1.6M
Mechanism-based therapies for photoreceptor degenerationR01EY025225 · NEI · UNIVERSITY OF IOWA · PI MAHAJAN, VINIT B · 2015 to 2018
$1.3M
Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS CellsR21AG050437 · NIA · UNIVERSITY OF IOWA · PI BASSUK, ALEXANDER G, MAHAJAN, VINIT B · 2015 to 2016
$431k
NCI NIH HHS P30 CA013696NEI NIH HHS P30 EY019007NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY018213NEI NIH HHS R01 EY024665NEI NIH HHS R01 EY024698NEI NIH HHS R01 EY025225NEI NIH HHS R01 EY026682NIA NIH HHS R21 AG050437NIGMS NIH HHS T32 GM007337
6 · The paper itself

Abstract

Hyperopia (farsightedness) is a common and significant cause of visual impairment, and extreme hyperopia (nanophthalmos) is a consequence of loss-of-function MFRP mutations. MFRP deficiency causes abnormal eye growth along the visual axis and significant visual comorbidities, such as angle closure glaucoma, cystic macular edema, and exudative retinal detachment. The Mfrp

Indexed as

AdultAnimalsAxial Length, EyeChild, PreschoolDependovirusEye ProteinsFemaleFrizzled-Related ProteinsGenetic TherapyHumansMaleMembrane ProteinsMiceMiddle AgedRetinal DegenerationRetinal Pigment EpitheliumEye ProteinsFrizzled-Related ProteinsMembrane ProteinsMfrp protein, mouse

Identifiers

PMID29170418
PMCPMC5701072
OpenAlexW2769740873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.